SCHEMBL22148904

SCHEMBL22148904

Fc1nc(F)c(F)c(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2)c1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ MEN1 O00255 6/20 0.44
▸ KMT2A Q03164 6/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ ADORA2A P29274 3/20 0.42
▸ ADORA1 P30542 3/20 0.42
▸ ADORA3 P0DMS8 2/20 0.42
▸ ADORA2B P29275 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ NTSR1 P30989 1/20 0.40
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ LMNA P02545 4/20 0.39
▸ ATM Q13315 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21888537 0.90 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL21562893 0.90 ALDH1A1 (0.41) MEN1KMT2AALDH1A1MAPTNPC1
SCHEMBL21544310 0.89 MAPT (0.40) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL22148815 0.89 MEN1 (0.56) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL22148577 0.89 L3MBTL1 (0.44) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL21085456 0.88 L3MBTL1 (0.50) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL22148700 0.87 L3MBTL1 (0.42) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL23733855 0.86 L3MBTL1 (0.48) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL22148900 0.83 ADORA2A (0.44) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL28375304 0.81 ADORA2A (0.50) L3MBTL1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-06-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES NDUFV3, NDUFV2, CRY2 L3MBTL1 1938/4885MEN1 2193/4885KMT2A 4367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback